GlassScriptPhysician profile
Lance W Chapman
NPI 1194143438
$10,582.57
in general payments reported to CMS, 2019-2025
34 companies · $2,553 in 2025
The $2,553 reported for 2025 was more than what 92% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.99 · 2020: $1,002 · 2021: $1,321 · 2022: $1,367 · 2023: $1,775 · 2024: $2,496 · 2025: $2,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,666 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,665.61 |
| Education | $158.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,820.53 | 2020-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $1,329.42 | 2020-2025 | Otezla, Otezla |
| Genzyme Corporation | $1,039.27 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $903.98 | 2020-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $733.52 | 2020-2025 | Tremfya, Stelara, Simponi Aria |
| Ucb, INC. | $455.81 | 2021-2025 | Bimzelx |
| Pfizer INC. | $449.95 | 2019-2025 | |
| Mimedx Group, INC. | $407.11 | 2024-2025 | |
| Galderma Laboratories, L.P. | $311.62 | 2021-2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $288.89 | 2020-2025 | |
| Incyte Corporation | $252.28 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $241.94 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $241.81 | 2021-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $224.15 | 2022-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $144.04 | 2021-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $128.72 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $91.56 | 2020-2024 | Duobrii, Siliq |
| Organogenesis INC. | $61.77 | 2021-2022 | |
| Medimetriks Pharmaceuticals, INC. | $52.82 | 2020-2021 | |
| Allergan, INC. | $42.08 | 2019-2020 | |
| Boston Scientific Corporation | $41.74 | 2023 | Wavewriter Alpha Prime 16 |
| Elekta, INC. | $40.76 | 2024 | Elekta Medical Linear Accelerator |
| Epi Health, LLC | $36.16 | 2022 | |
| Misonix INC | $30.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.55 | 2025 | Spevigo |
| Revance Therapeutics, INC. | $27.04 | 2024 | Daxxify |
| Dermira, INC. | $24.82 | 2020 | |
| Almirall LLC | $22.55 | 2020 | |
| Vyne Pharmaceuticals INC. | $19.29 | 2020 | |
| Strata Skin Sciences, INC. | $18.25 | 2025 | Xtrac |
| Paratek Pharmaceuticals, INC. | $18.24 | 2025 | Nuzyra |
| Kyowa Kirin, INC. | $18.17 | 2025 | |
| Biofrontera INC. | $17.63 | 2022 | |
| Botanix Sb INC | $17.38 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.